| Longitudinal study of socioeconomic factors, stress-related biomarkers, and aggressive prostate cancer |
Kathryn Barry |
University of Maryland, Baltimore |
PLCO |
Jun 17, 2026 |
2026-0158 |
| Multi-population study of serum protein biomarkers and prostate cancer risk |
Sonja Berndt |
National Cancer Institute |
PLCO |
Jun 17, 2026 |
2026-0154 |
| Leveraging antibody responses against transposable elements as a novel immune therapy for ovarian cancer |
Rebecca Lynch |
The George Washington University School of Medicine and Health Sciences |
PLCO |
Jun 17, 2026 |
2026-0096 |
| Exosome-based microRNA Biomarkers for Non-invasive and Early Detection of Colorectal Cancer and Advanced Adenomas |
Ajay Goel |
City of Hope |
PLCO |
Jun 16, 2026 |
2025-0016 |
| Efficient Design and Analysis of Two-Phase Biomarker Studies |
Li Cheung |
National Cancer Institute |
PLCO |
Jun 8, 2026 |
PLCO-2053 |
| Impact of deep learning lung cancer risk models on clinical decisions with blood-based diagnostics |
Michael Kammer |
Biodesix, inc |
NLST |
Jun 8, 2026 |
NLST-1515 |
| Scalable and Reproducible Deep Learning Strategies for Lung Cancer Screening Imaging |
Stefano Diciotti |
Alma Mater Studiorum - Department DEI |
NLST |
Jun 1, 2026 |
NLST-1514 |
| Heterogeneity of screening effects (Original Project: NLST-1098) |
Hormuzd Katki |
American Cancer Society |
NLST |
May 29, 2026 |
NLST-1509 |
| Behavioral effects of screening offers |
Ethan Lieber |
University of Notre Dame du Lac |
PLCO |
May 29, 2026 |
PLCO-2044 |
| Estimating the intake of moderation foods and evaluating associations with metabolomic and microbiome measures |
Kaelyn Burns |
National Cancer Institute |
IDATA |
May 11, 2026 |
IDATA-99 |
| Studies to use extended NLST follow-up data (Original Project: NLST-626) |
Hormuzd Katki |
American Cancer Society |
NLST |
May 11, 2026 |
NLST-1508 |
| Validation of the Michigan General Cancer Screening Model (M-GCSM) Using the National Lung Screening Trial Dataset |
Tanner Caverly |
Department of Veterans Affairs |
NLST |
May 11, 2026 |
NLST-1513 |
| Using Surrogate Endpoints to Improve the Design and Analysis of Randomized Screening Trials |
Yingqi Zhao |
Fred Hutchinson Cancer Center |
NLST |
May 4, 2026 |
NLST-1511 |
| Estimating the intake of moderation foods and evaluating associations with risk of cancer and mortality |
Kaelyn Burns |
National Cancer Institute |
PLCO |
May 4, 2026 |
PLCO-2045 |
| Wildfire Smoke Exposure and Cancer- and Aging-Related Outcomes in the PLCO Cohort |
Shuguang Leng |
University of New Mexico HSC |
PLCO |
Apr 28, 2026 |
PLCO-2041 |
| Reexamine trial outcomes in PLCO to identify interactions of screening effects with screen results and other covariates (Original Project: PLCO-1091) |
Hormuzd Katki |
American Cancer Society |
PLCO |
Apr 28, 2026 |
PLCO-2043 |
| Deep Learning to Improve Screening of Interstitial Lung Diseases |
Asif Abdul Hameed |
Henry Ford Health |
NLST |
Apr 28, 2026 |
NLST-1505 |
| Estimating the lung cancer mortality benefit of screening within lung cancer risk strata in the National Lung Screening Trial (Original Project: 201204-0017) |
Hormuzd Katki |
American Cancer Society |
NLST |
Apr 28, 2026 |
NLST-1507 |
| Continuation of DCPP (PLCO-286/PLCO-287) |
Stephanie Smith-Warner |
Harvard TH Chan School of Public Health |
PLCO |
Apr 27, 2026 |
PLCO-2042 |
| Association between microplastic exposure and risk of never-smoking lung cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial |
Qing Lan |
National Cancer Institute |
PLCO |
Apr 21, 2026 |
2025-0048 |
